News

Best Immunotherapy for Glioblastoma stage 4

by

Immunotherapy for Glioblastoma stage 4 in Germany

Immunotherapy for Glioblastoma stage 4

We organize your clinic for immunotherapy for glioblastoma at best clinics in Germany.

Stage 4 glioblastoma (also called GBM) is the most aggressive type of primary brain tumor. Standard treatment usually includes surgery, radiation, and chemotherapy (often with Temozolomide).

When someone is offered immunotherapy including dendritic cell therapy, it means doctors are trying to use the patient’s immune system to recognize and attack the tumor. However, Germany is the leader in immunotherapy for glioblastoma stage 4, when it comes to advanced immunotherapies such as dendritic cell vaccination.

What immunotherapy in glioblastoma means

Immunotherapy is a broad group of treatments designed to help the immune system fight cancer.

In glioblastoma, the idea is to:

  • train immune cells to recognize tumor-specific proteins
  • stimulate immune cells to enter the brain and attack tumor cells
  • help the body remember the tumor so it keeps fighting it

Are there new or experimental treatments?

Yes there are. Find the following new immunotherapy for glioblastoma stage 4:

    • Dendritic cell vaccines
    • immune checkpoint inhibitors
    • Oncolytic Virus-therapy (Newcastle virus)
    • Peptide vaccines

However, the treatment with immunotherapy for glioblastoma stage 4 is only effective if you combine oncolytic viro-therapy with dendritic cell vaccination.

What Oncolytic Viro-Therapy With Newcastle Virus Means

 

Oncolytic viro-therapy with Newcastle disease virus is a special type of immunotherapy for glioblastoma stage 4 that uses a virus to help the body fight cancer cells. It may sound surprising to use a virus as treatment, but the idea is actually quite logical. Some viruses can infect and destroy cancer cells much more easily than healthy cells. Scientists discovered that the Newcastle virus, which normally infects birds, has this property. For humans it is usually harmless, but for certain tumor cells it can act like a targeted attacker.

In simple terms, the virus is used to wake up the immune system. After the virus enters the body, it infects tumor cells and causes them to break apart. When those cells die, they release tumor signals that the immune system can finally recognize. German doctors sometimes describe this as “training the immune system.” Another helpful translation word often used in research is “tumor-selective virus,” meaning the virus mainly targets cancer cells rather than normal tissue.

 

How Newcastle Virus Helps the Immune System Fight the Tumor

 

The goal of this approach is to stimulate a stronger immune reaction against the brain tumor. In immunotherapy for glioblastoma stage 4, this virus therapy is often combined with other treatments such as dendritic cell therapy. The virus infects the tumor cells, damages them, and makes them easier for immune cells to detect. At the same time, the infection triggers inflammation, which signals the immune system that something dangerous is present.

Another translation word doctors use is “oncolysis.” This simply means “destruction of cancer cells.” When the virus causes oncolysis, tumor fragments become visible to immune cells such as T-cells. These cells can then search the body for other tumor cells with the same markers. This immune activation is one reason Newcastle virus therapy is being studied as immunotherapy for glioblastoma stage 4.

For patients, the therapy may be given through injections, sometimes together with tumor-based vaccines. Researchers hope it can slow tumor growth, support the immune response, and potentially extend survival in difficult cancers. The term “virotherapy” itself is another translation word that simply means using viruses as treatment.
However, it is important to know that this method is still considered experimental in many places.

Clinical studies continue to investigate how effective it is and which patients benefit the most. For some people, doctors see it as a complementary option within immunotherapy for glioblastoma stage 4, especially when standard treatments alone are not enough.

What is dendritic cell therapy and how does it work?

 

How is Dendritic cell therapy working?

 

Dendritic cells are special immune cells whose job is to show the immune system what to attack.

Think of them as “teachers” for immune cells. How dendritic cell therapy usually works.

 

  1. Oncolytic viro-therapy with Newcastle virus is mandatory to detect the tumor antigen!
  2. Blood is taken from the patient.
  3. Doctors collect tumor antigen cells from the blood.
  4. Dendritic cells are grown in the lab.
  5. Scientists isolate and grow dendritic cells.
  6. Tumor antigen information is added.
  7. The “trained” dendritic cells are injected into the body after 8 days.
  8. Immune system attack begins and sets memory cells in your bone marrow.
  9. These cells show T-cells how to recognize glioblastoma cells and trigger an immune attack.

A well-known example being studied is the vaccine IO-VAC® used in Germany since 10 years!.

Why doctors use oncolytic viro-therapy and dendritic cell therapy for glioblastoma

Doctors may consider this therapy when:

  • Standard options are used already
  • The tumor returned after standard treatment
  • They want to extend survival or slow recurrence
  • No other treatment is left

Potential benefits of immunotherapy for glioblastoma stage 4

Possible advantages:

  • Personalized to the patient’s own tumor.
  • Usually fewer side effects than chemotherapy.
  • Help slow tumor growth.
  • In some studies, patients lived longer than expected.

Treatment of glioblastoma stage 4 with dendritic cells in Germany

Are there any side effects of dendritic cell vaccination?

Side effects are often milder than chemotherapy, but can include:

fever
fatigue
injection-site reactions
headache
flu-like symptoms

Serious complications are uncommon but possible.

How long can you live with glioblastoma stage 4?

Survival with immunotherapy and dendritic cell vaccination for glioblastoma stage 4

Life expectancy and chances of survival

One of the first things you want to know is:

“How long can someone live with stage 4 glioblastoma?”
“What is the survival rate?”

You want to understand realistic expectations.

Survival with immunotherapy and dendritic cell vaccination for glioblastoma

The best-known vaccine trial is with IO-Vac®

According to large clinical trials:

Median survival: about 19.3 months with the vaccine vs 16.5 months with standard care alone.

Risk of death reduced by about 20%.

Long-term survival improved somewhat:

4-year survival: about 15.7% vs 9.9% without immunotherapy incl. DCV.

5-year survival: about 13% vs 5.7% without immunotherapy incl. DCV.

So the treatment does not cure most patients, but it may extend survival and create a small group of long-term survivors. However, Immunotherapy for glioblastoma stage 4 may increase average survival by a few months and improve the chance of long-term survival for some patients,

Clinical trials for the treatment with immunotherapy for glioblastoma stage 4

Dendritic Cell-Based Immunotherapy clinical trials:

Find the best Clinic for Glioblastoma treatment in Germany

Germany is a leader in medical innovation, particularly in the field of immunotherapies. Patients seeking Treatment of Glioblastoma stage 4 with Dendritic Cells in Germany can find the best clinics and medical professionals, supported by our comprehensive medical concierge services.

Our organization helps patients navigate the complexities of receiving treatment abroad, ensuring they have access to top-tier medical care and the best possible outcomes.

Surgical Experts stands out for its commitment to patient care, offering services such as:

  • Expert Medical Consultation: Personalized assessments to identify the most suitable treatment options.
  • Coordination with Leading Hospitals: Connections with top clinics that specialize in immunotherapy for glioblastoma.
  • Comprehensive Travel Support: Assistance with travel logistics, including flights, visas, and accommodation.
  • Dedicated Patient Support: Continuous guidance and support throughout the treatment journey.

Choosing Surgical Experts ensures that patients benefit from the latest advancements in dendritic cell vaccination while receiving world-class care in Germany’s premier medical facilities.

 

Let’s find out if you are candidate for the treatment with Immunotherapy for Glioblastoma stage 4.

Contact us